ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
KYOWA, Bora Pharmaceuticals Enter Mfg. Pact
August 11, 2021Upon approval in Japan, Bora will be the commercial manufacturing site for the generic product production. -
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan
August 05, 2021KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing in Japan. -
FDA approves Kyowa Kirin’s Nourianz drug for Parkinson’s disease
September 03, 2019The US Food and Drug Administration (FDA) has approved Japanese company Kyowa Kirin’s drug Nourianz (istradefylline) as an add-on to the existing drug levodopa/carbidopa to treat adults... -
Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US
April 18, 2019Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US. -
Astellas and Lupin’s subsidiary Kyowa enter into an agreement
February 28, 2017Kyowa to exclusively market Quetiapine Fumarate extended-release tablets in Japan
Pharma Sources Insight January 2025
